Two new oral antivirals for covid-19: ▼molnupiravir and ▼nirmatrelvir plus ritonavir | Drug and Therapeutics Bulletin

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Citation Tools

DTB drug review

Two new oral antivirals for covid-19: ▼molnupiravir and ▼nirmatrelvir plus ritonavir

Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Two new oral antivirals for covid-19: ▼molnupiravir and ▼nirmatrelvir plus ritonavir

Drug and Therapeutics Bulletin 2022;60:73-77.